Literature DB >> 9458933

Review: analogies between trophoblastic and malignant cells.

C A Mullen1.   

Abstract

PROBLEM: The question of how trophoblastic and malignant cells evade immunologic recognition and rejection by their host was studied. METHOD OF STUDY: A literature review was conducted.
RESULTS: Trophoblastic and malignant cells share a number of similarities. These include a lack of major histocompatibility complex antigen expression, resistance to lysis by natural killer cells, T-helper cell-2 (TH2)-biased response, prostaglandin E production, and response to transforming growth factor beta. In addition, the analogies between trophoblastic and malignant cells extend into immunotherapy in which anti-idiotype therapy has a viable role in the prevention of pregnancy loss and the treatment of cancer.
CONCLUSIONS: Trophoblastic and malignant cells use a number of similar mechanisms to resist rejection by their host. By using similar strategies these cells are able to successfully co-exist in an immunologically hostile environment.

Entities:  

Mesh:

Year:  1998        PMID: 9458933     DOI: 10.1111/j.1600-0897.1998.tb00332.x

Source DB:  PubMed          Journal:  Am J Reprod Immunol        ISSN: 1046-7408            Impact factor:   3.886


  9 in total

1.  Differential expression of E-cadherin, β-catenin, and Lewis x between invasive hydatidiform moles and post-molar choriocarcinomas.

Authors:  Jean-Jacques Candelier; Lucien Frappart; Ange Lucien Diatta; Tarik Yadaden; Mamadou-Lamine Cissé; Jean-Marie Afoutou; Jean-Yves Picard; Benoît Mennesson; Rima Slim; Karim Si-Tayeb; Philippe Coullin
Journal:  Virchows Arch       Date:  2013-05-17       Impact factor: 4.064

2.  YB-1 Is Altered in Pregnancy-Associated Disorders and Affects Trophoblast in Vitro Properties via Alternation of Multiple Molecular Traits.

Authors:  Violeta Stojanovska; Aneri Shah; Katja Woidacki; Florence Fischer; Mario Bauer; Jonathan A Lindquist; Peter R Mertens; Ana C Zenclussen
Journal:  Int J Mol Sci       Date:  2021-07-05       Impact factor: 5.923

3.  Expression of full-length p53 and its isoform Deltap53 in breast carcinomas in relation to mutation status and clinical parameters.

Authors:  Lars O Baumbusch; Simen Myhre; Anita Langerød; Anna Bergamaschi; Stephanie B Geisler; Per E Lønning; Wolfgang Deppert; Irene Dornreiter; Anne-Lise Børresen-Dale
Journal:  Mol Cancer       Date:  2006-10-20       Impact factor: 27.401

Review 4.  Cross Talk between Cancer and Mesenchymal Stem Cells through Extracellular Vesicles Carrying Nucleic Acids.

Authors:  Tatiana Lopatina; Chiara Gai; Maria Chiara Deregibus; Sharad Kholia; Giovanni Camussi
Journal:  Front Oncol       Date:  2016-05-23       Impact factor: 6.244

5.  Association of lncRNA SH3PXD2A-AS1 with preeclampsia and its function in invasion and migration of placental trophoblast cells.

Authors:  Qian Chen; Sijia Jiang; Haihua Liu; Yue Gao; Xiaoxue Yang; Zhonglu Ren; Yunfei Gao; Lu Xiao; Haoyue Hu; Yanhong Yu; Xinping Yang; Mei Zhong
Journal:  Cell Death Dis       Date:  2020-07-27       Impact factor: 8.469

Review 6.  A Hypothetical Model Suggesting Some Possible Ways That the Progesterone Receptor May Be Involved in Cancer Proliferation.

Authors:  Jerome H Check; Diane L Check
Journal:  Int J Mol Sci       Date:  2021-11-16       Impact factor: 5.923

7.  Placental pseudo-malignancy from a DNA methylation perspective: unanswered questions and future directions.

Authors:  Boris Novakovic; Richard Saffery
Journal:  Front Genet       Date:  2013-12-10       Impact factor: 4.599

Review 8.  Exploring the links between cancer and placenta development.

Authors:  Vincenzo Costanzo; Alberto Bardelli; Salvatore Siena; Sergio Abrignani
Journal:  Open Biol       Date:  2018-06       Impact factor: 6.411

9.  Exosomal MicroRNAs in Pregnancy Provides Insight into a Possible Cure for Cancer.

Authors:  Preenan Pillay; Kogi Moodley; Manu Vatish; Jagidesa Moodley
Journal:  Int J Mol Sci       Date:  2020-07-29       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.